Invivogen
Menu

Anti-hEGFR-hIgA2

Product Unit size Cat. code Docs. Price

Anti-hEGFR-hIgA2

Human EGFR (cetuximab) antibody - Human IgA2

Show product

Custom size

hegfr-mab7

Monoclonal human IgA2 antibody against human EGFR

Anti-hEGFR-hIgA2 features the constant region of the human IgA2 isotype and the variable region of cetuximab. Cetuximab is a chimeric human/mouse IgG1 monoclonal antibody that targets epidermal growth factor receptor (EGFR), a cell surface receptor overexpressed in many types of cancer. EGFR is activated by binding specific ligands, including epidermal growth factor and transforming growth factor-α. Activation of EGFR promotes cell proliferation and survival, as well as angiogenesis, leading to tumor growth and metastasis. Binding of cetuximab to EGFR blocks ligand/receptor binding and induces receptor internalization and subsequent degradation. Consequently, cetuximab blocks downstream pathways which regulate cell growth and angiogenesis. In addition, cetuximab induces cell death through antibody-dependent cell-mediated cytotoxicity (ADCC) [1, 2]. Cetuximab has been approved by the FDA for the treatment of metastatic colorectal cancer and metastatic squamous cell carcinoma of the head and neck [3].
Anti-hEGFR-hIgA2 was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography with peptide M.

 

References:

1. Kurai J. et al., 2007. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res. 3(5):1552-61.
2. Kimura H. et al., 2007. Antibodydependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor. Cancer Sci. 98(8):1275-80.
3. Vincenzi B. et al., 2010. Cetuximab: from bench to bedside. Curr Cancer Drug Targets. 10(1):80-95.

Back to the top

Specifications

Specificity: Targets cells expressing human EGFR

Clonality: Monoclonal antibody

Isotype: Human IgA2, kappa

Source: CHO cells

Purity: Purified by affinity chromatography with peptide M

Quality control:

  • Binding of Anti-hEGFR-hIgA2 to human EGFR has been tested using flow cytometry.
  • The complete sequence of this antibody has been verified.
  • The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.
Back to the top

Contents

anti-hEGFR-hIgA2 antibody is provided azide-free and lyophilized.

  • 100 µg purified anti-hEGFR-hIgA2 antibody

room temperature Product is shipped at room temperature

Back to the top

This antibody has been removed from our catalog. However, you may contact us if you wish to order minimal quantities.

Customer Service
& Technical Support
Shopping cart is empty